Medicare Enrolled
Dr. Julie Bell, MD
Pathology - Anatomic · Vero Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bell? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bell
Dr. Julie Bell is a pathology - anatomic in Vero Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Bell performed 309,969 Medicare services across 167,504 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bell received a total of $1,568 from 12 pharmaceutical and/or device companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in FL$ $1,568 industry payments
Medicare Practice Summary
Medicare Utilization ↗309,969
Medicare services
Top 0% in FL for pathology - anatomic
167,504
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15,498 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 59,413 | $8 | $9 |
| Comprehensive metabolic blood panel | 39,898 | $10 | $22 |
| Complete blood count (CBC) with differential | 35,046 | $8 | $16 |
| Lipid panel (cholesterol and triglycerides) | 20,638 | $13 | $27 |
| Thyroid stimulating hormone (TSH) test | 17,537 | $16 | $34 |
| Hemoglobin A1c test (diabetes monitoring) | 14,833 | $9 | $20 |
| Urinalysis with microscopic exam | 11,326 | $3 | $7 |
| Basic metabolic blood panel | 7,338 | $8 | $17 |
| Creatinine test (kidney function) | 7,116 | $5 | $11 |
| Vitamin B-12 level test | 7,076 | $15 | $31 |
| Vitamin D level test | 6,983 | $29 | $60 |
| Free thyroxine (T4) test | 6,956 | $9 | $19 |
| Urine microalbumin test (kidney screening) | 5,325 | $6 | $13 |
| Ferritin level test (iron stores) | 5,069 | $13 | $28 |
| Iron level test | 4,614 | $6 | $13 |
| Iron binding capacity test | 4,486 | $8 | $18 |
| PSA test (prostate cancer screening) | 4,027 | $18 | $37 |
| Parathyroid hormone level test | 3,845 | $40 | $83 |
| Kidney function blood test panel | 3,173 | $8 | $18 |
| Folic acid level test | 2,927 | $14 | $30 |
| Complete blood count (CBC), automated | 2,435 | $6 | $13 |
| Uric acid level test | 2,315 | $4 | $10 |
| Magnesium level test | 2,210 | $7 | $14 |
| C-reactive protein test (inflammation marker) | 2,137 | $5 | $11 |
| Prothrombin time test (blood clotting) | 2,043 | $4 | $9 |
| Total protein level, urine | 1,965 | $4 | $8 |
| Carcinoembryonic antigen (cea) protein level | 1,888 | $18 | $38 |
| Lactate dehydrogenase (enzyme) level | 1,489 | $6 | $13 |
| Blood count, hemoglobin | 1,315 | $2 | $5 |
| Liver function blood test panel | 1,305 | $8 | $17 |
| Red blood cell concentration measurement | 1,303 | $2 | $5 |
| Prostate cancer screening; prostate specific antigen test (psa) | 1,111 | $19 | $39 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 1,057 | $17 | $36 |
| Phosphate level test | 1,020 | $5 | $10 |
| Sed rate test (inflammation marker) | 990 | $3 | $6 |
| Testosterone (hormone) level, total | 940 | $25 | $52 |
| Creatine kinase (cardiac enzyme) level, total | 874 | $6 | $14 |
| Screening test for autoimmune disorder | 741 | $12 | $25 |
| Tissue pathology examination, moderate complexity | 703 | $28 | $250 |
| Red blood count, automated test | 635 | $4 | $8 |
| Thyroid hormone, t3 measurement, free | 616 | $16 | $34 |
| Bilirubin level, direct | 593 | $5 | $11 |
| Immunoglobulin level test | 586 | $9 | $19 |
| Coagulation assessment blood test, plasma or whole blood | 542 | $6 | $13 |
| Rheumatoid factor level | 541 | $5 | $12 |
| Ldl cholesterol level | 539 | $10 | $21 |
| Automated urinalysis | 533 | $2 | $5 |
| Liver enzyme (sgpt), level | 472 | $5 | $11 |
| Special stained specimen slides to examine tissue including interpretation and report | 472 | $9 | $96 |
| Natriuretic peptide (heart and blood vessel protein) level | 403 | $38 | $79 |
| Blood creatinine level | 373 | $5 | $11 |
| Hdl cholesterol level | 370 | $8 | $17 |
| Triglycerides level | 370 | $6 | $12 |
| Lipase (fat enzyme) level | 367 | $7 | $14 |
| Measurement of antibody for assessment of autoimmune disorder, titer | 357 | $11 | $23 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 355 | $16 | $32 |
| Thyroxine (thyroid chemical), total | 354 | $7 | $14 |
| Cortisol (hormone) measurement, total | 285 | $15 | $33 |
| Measurement of dna antibody, native or double stranded | 279 | $13 | $28 |
| Liver enzyme (sgot), level | 273 | $5 | $11 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 240 | $20 | $42 |
| Tuberculosis test, gamma interferon | 219 | $59 | $124 |
| Amylase (enzyme) level | 214 | $6 | $13 |
| Urea nitrogen level to assess kidney function, quantitative | 201 | $4 | $8 |
| Pathology examination of tissue using a microscope, moderately high complexity | 196 | $62 | $401 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 193 | $20 | $42 |
| Preparation of tissue for examination by removing any calcium present | 190 | $10 | $78 |
| Calcium level, total | 188 | $5 | $11 |
| Glycated protein level | 183 | $16 | $34 |
| Thyroid hormone evaluation | 170 | $6 | $13 |
| Pathology examination of specimen during surgery, first tissue block | 168 | $47 | $310 |
| Measurement of total estradiol (hormone) | 156 | $27 | $56 |
| Haptoglobin (serum protein) level | 139 | $12 | $26 |
| Blood potassium level | 136 | $5 | $10 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 135 | $18 | $38 |
| Urine sodium level | 132 | $5 | $11 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 130 | $20 | $42 |
| Bone marrow, smear interpretation | 119 | $37 | $264 |
| Glutamyltransferase (liver enzyme) level | 100 | $7 | $15 |
| Smear for infectious agents | 99 | $6 | $12 |
| Tissue fungi or parasites | 96 | $4 | $9 |
| Microsomal antibodies (autoantibody) measurement | 95 | $14 | $30 |
| Troponin (protein) analysis, quantitative | 93 | $12 | $25 |
| Platelet count, automated test | 92 | $4 | $9 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 87 | $12 | $26 |
| C-peptide (protein) level | 85 | $20 | $42 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 81 | $16 | $34 |
| Albumin (protein) level | 76 | $5 | $10 |
| Creatinine clearance measurement to test for kidney function | 71 | $9 | $19 |
| Gonadotropin, luteinizing (reproductive hormone) level | 70 | $18 | $38 |
| Total protein level, blood | 70 | $4 | $8 |
| Protein measurement, serum | 68 | $14 | $100 |
| Tissue staining for diagnosis, additional | 67 | $22 | $250 |
| Blood smear interpretation by physician with written report | 61 | $19 | $118 |
| Blood glucose (sugar) level | 57 | $4 | $8 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 57 | $18 | $37 |
| Digoxin level, total | 54 | $13 | $27 |
| Prolactin (milk producing hormone) level | 54 | $18 | $39 |
| Alpha-fetoprotein (afp) level, serum | 50 | $15 | $34 |
| Evaluation of fine needle aspirate with interpretation and report | 50 | $53 | $345 |
| Immunologic analysis technique on serum (immunofixation) | 46 | $14 | $82 |
| Thyroglobulin (thyroid protein) antibody measurement | 44 | $16 | $32 |
| Detection test by immunoassay with direct visual observation for influenza virus | 36 | $16 | $34 |
| Tissue staining for diagnosis, initial | 36 | $26 | $250 |
| Thyroid hormone, t3 measurement, total | 32 | $14 | $29 |
| Progesterone (reproductive hormone) level | 31 | $20 | $42 |
| Cell examination of specimen, selective cellular enhancement technique | 31 | $21 | $195 |
| Coagulation function measurement, qualitative or semiquantitative | 29 | $10 | $20 |
| Pathology examination of tissue using a microscope, limited examination | 26 | $4 | $68 |
| Pathology examination of tissue using a microscope, high complexity | 25 | $110 | $629 |
| Special gram or giemsa stain for microorganism | 23 | $4 | $9 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 18 | $22 | $70 |
| Special stained specimen slides to identify organisms including interpretation and report | 16 | $18 | $158 |
| Pathology examination of tissue using a microscope, moderately low complexity | 15 | $8 | $175 |
| Screening test for mononucleosis (mono) | 14 | $5 | $11 |
| Blood glucose (sugar) tolerance test, 3 specimens | 12 | $13 | $26 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 11 | $135 | $750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
0.0% medium
99.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,568
Total received (2018-2024)
Avg $261/year across 6 years
Top 10% in FL for pathology - anatomic
12
Companies
16
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,568 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$249
2023$262
2022$579
2021$125
2020$40
2018$314
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$249
Incyte Corporation
$228
Genentech USA, Inc.
$203
Taiho Oncology, Inc.
$125
TAIHO ONCOLOGY, INC.
$124
Amgen Inc.
$124
Astellas Pharma US Inc
$124
JAZZ PHARMACEUTICALS INC.
$123
Lilly USA, LLC
$88
Roche Diagnostics Corporation
$87
Celgene Corporation
$50
ABIOMED
$40
Top 3 companies account for 43.4% of total payments
Associated products mentioned in payments ›
ENHERTU · Impella · JAKAFI · LONSURF · Lonsurf · MONJUVI · Perjeta · REBLOZYL · TECENTRIQ · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pathology - anatomic in FL.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Pathology - Anatomics within 10 mi
6
Per 100K population
3.7
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bell is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 10%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bell experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Bell performed 59,413 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bell receive payments from pharmaceutical companies?
Yes. Dr. Bell received a total of $1,568 from 12 companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bell's costs compare to other pathology - anatomics in Vero Beach?
Dr. Bell's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pathology - Anatomics in Vero Beach
Browse pathology - anatomics in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Pathology - Anatomics in FL
Pathology - Anatomics ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pathology - Anatomics in FL
Which FL pathology - anatomics receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc..
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology